The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial

BACKGROUND: The OPTION trial results showed that premenopausal women with early stage breast cancer (EBC) receiving chemotherapy benefited from ovarian function protection with goserelin. The impact of treatments on patient reported Quality of Life (QoL) were also examined. PATIENTS AND METHODS: 227...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Breast
Main Authors: R, Leonard, A, Yellowlees, J, Mansi, L, Fallowfield, V, Jenkins
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2020
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7303950/
https://ncbi.nlm.nih.gov/pubmed/32505861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2020.05.009
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares